With Reference to above subject and in compliance with the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 we hereby submit the outcome of the meeting of the Board ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Camex Ltd's Board approved unaudited financial results for Q2 and H1 FY26 (ended September 30, 2025). Revenue from operations rose to Rs. 37.22 crore in Q2 (up ~8% YoY) and Rs. 71.59 crore for H1 (up ~5% YoY). However, profitability collapsed sharply: Q2 swung to a net loss of Rs. 0.28 crore versus a profit of Rs. 1.46 crore last year, while H1 net profit fell ~70% to Rs. 0.62 crore from Rs. 2.07 crore. The Dyes & Chemicals segment turned loss-making at the operating level. Operating cash flow remained negative at Rs. -4.65 crore for H1. The Board also approved increasing authorised share capital from Rs. 11 crore to Rs. 25 crore, and a material related party transaction of up to Rs. 50 crore for corporate guarantee/security from related party Camex Speciality Pvt Ltd, both subject to shareholder approval via postal ballot.
Sharp drop in profitability despite modest revenue growth signals margin pressure and weak demand in the Dyes & Chemicals segment, which is concerning for shareholders. The proposed capital hike and Rs. 50 crore related-party guarantee could lead to equity dilution and raise corporate governance questions.